Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation and Modification of the Japanese Classification System for Liver Metastases from Colorectal Cancer: A Multi-institutional Study.
Shinto E, Takahashi K, Yamaguchi T, Hashiguchi Y, Kotake K, Itabashi M, Yasuno M, Kanemitsu Y, Nishimura G, Akagi Y, Sato T, Kato T, Matsumoto H, Hase K, Sugihara K; Study Group for Liver Metastasis projected by the Japanese Society for Cancer of the Colon and Rectum (JSCCR). Shinto E, et al. Among authors: yasuno m. Ann Surg Oncol. 2015 Nov;22(12):3888-95. doi: 10.1245/s10434-015-4470-y. Epub 2015 Mar 11. Ann Surg Oncol. 2015. PMID: 25758188
Is total mesorectal excision always necessary for T1-T2 lower rectal cancer?
Kobayashi H, Mochizuki H, Kato T, Mori T, Kameoka S, Shirouzu K, Saito Y, Watanabe M, Morita T, Hida J, Ueno M, Ono M, Yasuno M, Sugihara K. Kobayashi H, et al. Among authors: yasuno m. Ann Surg Oncol. 2010 Apr;17(4):973-80. doi: 10.1245/s10434-009-0849-y. Epub 2009 Dec 1. Ann Surg Oncol. 2010. PMID: 19953330
A multicenter phase II trial of mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808).
Uetake H, Yasuno M, Ishiguro M, Kameoka S, Shimada Y, Takahashi K, Watanabe T, Muro K, Baba H, Yamamoto J, Mizunuma N, Tamagawa H, Mochizuki I, Kinugasa Y, Kikuchi T, Sugihara K. Uetake H, et al. Among authors: yasuno m. Ann Surg Oncol. 2015 Mar;22(3):908-15. doi: 10.1245/s10434-014-4094-7. Epub 2014 Dec 3. Ann Surg Oncol. 2015. PMID: 25465375 Clinical Trial.
mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the final analysis for survival.
Yasuno M, Uetake H, Ishiguro M, Mizunuma N, Komori T, Miyata G, Shiomi A, Kagimura T, Sugihara K. Yasuno M, et al. Int J Clin Oncol. 2019 May;24(5):516-525. doi: 10.1007/s10147-018-01393-8. Epub 2019 Jan 5. Int J Clin Oncol. 2019. PMID: 30612267 Free PMC article. Clinical Trial.
146 results